• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by P3 Health Partners Inc. (Amendment)

    2/14/24 10:34:56 AM ET
    $PIII
    Medical/Nursing Services
    Health Care
    Get the next $PIII alert in real time by email
    SC 13G/A 1 d765434dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Amendment #2

    Under the Securities and Exchange Act of 1934

     

     

    P3 Health Partners Inc

    (Name of Issuer)

    Class A Common Stock

    (Title of Class of Securities)

    744413105

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    This Schedule is filed pursuant to Rule 13d-1(b)

    The information required in the remainder of this cover page (except any items to which the form provides a cross-reference) shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

     

     

     


    CUSIP NO. 744413105

     

     1)   

     Name of Reporting Person

     Ameriprise Financial, Inc.

     

     S.S. or I.R.S. Identification No. of Above Person

     IRS No. 13-3180631

     2)  

     Check the Appropriate Box if a Member of a Group

     (a) ☐  (b) ☒*

     

    *   This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

     

     3)  

     SEC Use Only

     

     4)  

     Citizenship or Place of Organization

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5)    

     Sole Voting Power

     

     0

       6)   

     Shared Voting Power

     

     5,441,489

       7)   

     Sole Dispositive Power

     

     0

       8)   

     Shared Dispositive Power

     

     5,441,489

     9)   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     5,441,489

    10)  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11)  

     Percent of Class Represented by Amount In Row (9)

     

     4.72%

    12)  

     Type of Reporting Person

     

     HC

     


    CUSIP NO. 744413105

     

     1)   

     Name of Reporting Person

     Columbia Management Investment Advisers, LLC

     

     S.S. or I.R.S. Identification No. of Above Person

     IRS No. 41-1533211

     2)  

     Check the Appropriate Box if a Member of a Group

     (a) ☐  (b) ☒*

     

    *   This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

     

     3)  

     SEC Use Only

     

     4)  

     Citizenship or Place of Organization

     

     Minnesota

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5)    

     Sole Voting Power

     

     0

       6)   

     Shared Voting Power

     

     5,441,489

       7)   

     Sole Dispositive Power

     

     0

       8)   

     Shared Dispositive Power

     

     5,441,489

     9)   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     5,441,489

    10)  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11)  

     Percent of Class Represented by Amount In Row (9)

     

     4.72%

    12)  

     Type of Reporting Person

     

     IA

     


    CUSIP NO. 744413105

     

     1)   

     Name of Reporting Person

     Columbia Wanger Asset Management, LLC

     

     S.S. or I.R.S. Identification No. of Above Person

     IRS No. 04-3519872

     2)  

     Check the Appropriate Box if a Member of a Group

     (a) ☐  (b) ☒*

     

    *   This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

     

     3)  

     SEC Use Only

     

     4)  

     Citizenship or Place of Organization

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5)    

     Sole Voting Power

     

     0

       6)   

     Shared Voting Power

     

     600,598

       7)   

     Sole Dispositive Power

     

     0

       8)   

     Shared Dispositive Power

     

     600,598

     9)   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     600,598

    10)  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     Not Applicable

    11)  

     Percent of Class Represented by Amount In Row (9)

     

     1.76%

    12)  

     Type of Reporting Person

     

     IA


    1(a)    Name of Issuer:    P3 Health Partners Inc
    1(b)    Address of Issuer’s Principal    2370 Corporate Circle, Suite 300
       Executive Offices:    Henderson, NV 89074
    2(a)    Name of Person Filing:    (a) Ameriprise Financial, Inc. (“AFI”)
          (b) Columbia Management Investment
          Advisers, LLC (“CMIA”)
          (c) Columbia Wanger Asset Management, LLC (“CWAM”)
    2(b)    Address of Principal Business Office:    (a) Ameriprise Financial, Inc.
          145 Ameriprise Financial Center
          Minneapolis, MN 55474
          (b) 290 Congress St.
          Boston, MA 02210
          (c) 71 S Wacker Dr., Suite 2500
          Chicago, IL 60606
    2(c)    Citizenship:    (a) Delaware
          (b) Minnesota
          (c) Delaware
    2(d)    Title of Class of Securities:    Class A Common Stock
    2(e)    Cusip Number:    744413105

     

    3

    Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):

    (a) Ameriprise Financial, Inc.

    A parent holding company in accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)

    (b) Columbia Management Investment Advisers, LLC

    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

    (c) Columbia Wanger Asset Management, LLC

    An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).


    4

    Incorporated by reference to Items (5)-(9) and (11) of the cover page pertaining to each reporting person.

    AFI, as the parent company of CMIA and CWAM, may be deemed to beneficially own the shares reported herein by those reporting persons. Accordingly, the shares reported herein by AFI include those shares separately reported herein by those reporting persons.

    Each of AFI, CMIA and CWAM disclaims beneficial ownership of any shares reported on this Schedule.

     

    5

    Ownership of 5% or Less of a Class:

    If this statement is being filed to report the fact as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following (X).

     

    6

    Ownership of more than 5% on Behalf of Another Person: Not Applicable

     

    7

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

    AFI: See Exhibit I

     

    8

    Identification and Classification of Members of the Group:

    Not Applicable

     

    9

    Notice of Dissolution of Group:

    Not Applicable

     

    10

    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.


    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 14, 2024

     

    Ameriprise Financial, Inc.
    By:   /s/ Michael G. Clarke
    Name:   Michael G. Clarke
    Title:   Senior Vice President, North America
      Head of Operations & Investor Services
    Columbia Management Investment
    Advisers, LLC
    By:   /s/ Michael G. Clarke
    Name:   Michael G. Clarke
    Title:   Senior Vice President, North America
      Head of Operations & Investor
      Services
    Columbia Wanger Asset Management, LLC
    By:   /s/ Michael G. Clarke
    Name:   Michael G. Clarke
    Title:   Chief Financial Officer and
      Assistant Treasurer
    Contact Information
    Dominic Geddes
    Global Head of Reporting
    Global Operations and Investor Services
    Telephone: +442074645779


    Exhibit Index

     

    Exhibit I    Identification and Classification of the Subsidiary which acquired the Security Being Reported on by the Parent Holding Company.
    Exhibit II    Joint Filing Agreement
    Get the next $PIII alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PIII

    DatePrice TargetRatingAnalyst
    4/1/2024Buy → Neutral
    BTIG Research
    9/1/2023$5.00Buy
    BTIG Research
    6/30/2023Market Perform
    TD Cowen
    1/4/2022Outperform
    William Blair
    More analyst ratings

    $PIII
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • P3 Health Partners downgraded by BTIG Research

      BTIG Research downgraded P3 Health Partners from Buy to Neutral

      4/1/24 7:39:12 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • BTIG Research initiated coverage on P3 Health Partners with a new price target

      BTIG Research initiated coverage of P3 Health Partners with a rating of Buy and set a new price target of $5.00

      9/1/23 7:31:24 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • TD Cowen initiated coverage on P3 Health Partners

      TD Cowen initiated coverage of P3 Health Partners with a rating of Market Perform

      6/30/23 7:34:42 AM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Financials

    Live finance-specific insights

    See more
    • P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter Earnings Conference Call Date & Time May 15, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call

      5/8/25 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results

      Revenue increased 18% year-over-year to $1.50 billion Affirming 2025 guidance Management to Host Conference Call and Webcast [March 27, 2025] at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. "Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention," said Aric Coffman, CEO of P3. "With the $130M+ in identified programmatic opportunities advancing our path to financial su

      3/27/25 4:22:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for the fourth quarter and full year 2024 on March 27, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter Earnings Conference Call Date & Time March 27, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call   The conference call will

      3/13/25 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    SEC Filings

    See more

    $PIII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $PIII
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $PIII
    Leadership Updates

    Live Leadership Updates

    See more

    $PIII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form DEF 14A filed by P3 Health Partners Inc.

      DEF 14A - P3 Health Partners Inc. (0001832511) (Filer)

      4/29/25 4:27:49 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • SEC Form PRE 14A filed by P3 Health Partners Inc.

      PRE 14A - P3 Health Partners Inc. (0001832511) (Filer)

      4/18/25 5:28:07 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - P3 Health Partners Inc. (0001832511) (Filer)

      4/16/25 8:09:19 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $81,552 worth of shares (160,000 units at $0.51) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/13/24 9:56:09 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $128,624 worth of shares (240,000 units at $0.54) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/12/24 8:12:24 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $117,544 worth of shares (240,000 units at $0.49) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/11/24 6:17:20 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health First Quarter Earnings Conference Call Date & Time May 15, 2025, 4:30pm Eastern Time Conference Call Details Toll-Free 1-833-316-0546 (US) International 1-412-317-0692 Ask to be joined into the P3 Health Partners call

      5/8/25 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will give a presentation on Thursday, April 10, 2025, at 9:45 AM Pacific Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3's investor relations webpage for 30 days following the presentation. About P3 Health Partners (NASDAQ:PIII): P3 Health Partners Inc. is a leading population health management company committed to transforming healthcare by improving the

      4/2/25 8:05:00 AM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results

      Revenue increased 18% year-over-year to $1.50 billion Affirming 2025 guidance Management to Host Conference Call and Webcast [March 27, 2025] at 4:30 PM ET P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. "Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention," said Aric Coffman, CEO of P3. "With the $130M+ in identified programmatic opportunities advancing our path to financial su

      3/27/25 4:22:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Names Leif Pedersen New Chief Financial Officer

      P3 Health Partners Inc. ("P3") (NASDAQ:PIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company. Pedersen was most recently Vice President of Finance & CFO Shared Services for Optum Health, a division of UnitedHealth Group. Prior to Optum Health, Pedersen served as Vice President of Finance & CFO IT at DaVita Medical Group. He brings m

      8/29/24 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • P3 Health Partners Names Dr. Aric Coffman as CEO

      P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ:PIII), today named Dr. Aric Coffman as P3's Chief Executive Officer, effective as of May 8, 2024, succeeding Dr. Sherif Abdou, P3's Co-Founder. Dr. Abdou will continue to serve as a Strategic Advisor to P3, and a member of the Company's Board of Directors working closely with Dr. Coffman to ensure a smooth transition. Dr. Coffman is an exceptional physician leader with a proven track record of success in the value-based care sector, most recently as the CEO of Honest Medical Group, a Rubicon Founders portfolio company. He brings over two decades of experience in leading provider organizations in delivering high quality, highly effici

      5/8/24 4:05:00 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • SEC Form 4 filed by Large owner Chicago Pacific Founders Ugp Iii, Llc

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      1/31/25 7:05:33 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • SEC Form 3 filed by new insider Pedersen Leif Elliott

      3 - P3 Health Partners Inc. (0001832511) (Issuer)

      10/1/24 5:35:14 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Large owner Chicago Pacific Founders Ugp Iii, Llc bought $81,552 worth of shares (160,000 units at $0.51) (SEC Form 4)

      4 - P3 Health Partners Inc. (0001832511) (Issuer)

      9/13/24 9:56:09 PM ET
      $PIII
      Medical/Nursing Services
      Health Care

    $PIII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by P3 Health Partners Inc.

      SC 13G - P3 Health Partners Inc. (0001832511) (Subject)

      11/14/24 4:33:46 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

      SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

      11/8/24 5:15:05 PM ET
      $PIII
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13D/A filed by P3 Health Partners Inc.

      SC 13D/A - P3 Health Partners Inc. (0001832511) (Subject)

      6/26/24 4:30:49 PM ET
      $PIII
      Medical/Nursing Services
      Health Care